Aortobronchial fistulae (ABF) are uncommon but potentially fatal anomalies. Patients may initially present with small volume hemoptysis, which can rapidly lead to massive hemoptysis and death if not diagnosed and intervened upon early. Diagnosis by imaging and bronchoscopy is not always conclusive; thus, a high index of suspicion is necessary to diagnose this life-threatening condition. Herein, we describe a case of a young man who had a late presentation of ABF 21 years following heart transplantation. This case illustrates the diagnostic and clinical challenge of ABF as a late sequela of cardiac transplantation and highlights the rarity of this anomaly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.transproceed.2019.08.029 | DOI Listing |
Ann Vasc Surg
January 2025
Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address:
Introduction: Aorto-bronchial or aorto-pulmonary fistulas (ABPF) are a rare but life-threatening complication following thoracic endovascular aortic repair (TEVAR). This narrative review aims to provide an overview of the current trends and available evidence on ABPF following TEVAR, evaluating risk factors, diagnostic approaches, and possible preventive and therapeutic strategies.
Methods: Relevant publications on post-TEVAR ABPF were selected through a literature search on PubMed.
The Publisher regrets that this article is an accidental duplication of an article that has already been published https://doi.org/10.1016/j.
View Article and Find Full Text PDFJTCVS Tech
October 2024
Department of Cardiothoracic Surgery, Emory University Hospitals, Atlanta, Ga.
J Vasc Interv Radiol
January 2025
Department of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Purpose: To investigate the effectiveness and safety of thoracic endovascular aortic repair (TEVAR) for infectious aortic diseases.
Materials And Methods: Patients who underwent TEVAR for infectious aortic diseases including infected thoracic aortic aneurysm, aortobronchial fistula (ABF), and aortoenteric fistula from December 2011 to October 2022 at 4 institutions were retrospectively studied. The primary outcome of the study was overall survival, whereas the secondary outcome was comprehensive adverse events.
Cardiovasc Pathol
November 2024
Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!